Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Phase 1b Open-Label, Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-110 in Combination with Abiraterone in Patients with Metastatic Prostate Cancer
Phase 1
Completed
- Conditions
- Metastatic Prostate Cancer
- Interventions
- Drug: ARV-110 in Combination with Abiraterone
- First Posted Date
- 2022-01-04
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Arvinas Androgen Receptor Inc.
- Target Recruit Count
- 4
- Registration Number
- 2024-516661-37-00
- Locations
- 🇫🇷
Assistance Publique Hopitaux De Paris, Paris, France
Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Arvinas Androgen Receptor, Inc.
- Target Recruit Count
- 248
- Registration Number
- NCT03888612
- Locations
- 🇺🇸
Clinical Trial Site, Charlottesville, Virginia, United States
News
No news found